Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
Identifieur interne : 000044 ( Main/Exploration ); précédent : 000043; suivant : 000045Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
Auteurs : Jason D. Goldman [États-Unis] ; George Diaz [États-Unis] ; Walter J. Urba [États-Unis]Source :
- International journal of antimicrobial agents [ 1872-7913 ] ; 2021.
Descripteurs français
- KwdFr :
- Antibactériens (usage thérapeutique), Antipaludiques (usage thérapeutique), Antiviraux (usage thérapeutique), Association médicamenteuse (MeSH), Azithromycine (usage thérapeutique), Essais cliniques comme sujet (MeSH), Humains (MeSH), Hydroxychloroquine (usage thérapeutique), Incertitude (MeSH), Politique (MeSH), Repositionnement des médicaments (MeSH).
- MESH :
English descriptors
- KwdEn :
- Anti-Bacterial Agents (therapeutic use), Antimalarials (therapeutic use), Antiviral Agents (therapeutic use), Azithromycin (therapeutic use), COVID-19 (drug therapy), COVID-19 (virology), Clinical Trials as Topic (MeSH), Drug Combinations (MeSH), Drug Repositioning (MeSH), Humans (MeSH), Hydroxychloroquine (therapeutic use), Politics (MeSH), SARS-CoV-2 (pathogenicity), Uncertainty (MeSH).
- MESH :
- chemical , therapeutic use : Anti-Bacterial Agents, Antimalarials, Antiviral Agents, Azithromycin, Hydroxychloroquine.
- drug therapy : COVID-19.
- pathogenicity : SARS-CoV-2.
- virology : COVID-19.
- Clinical Trials as Topic, Drug Combinations, Drug Repositioning, Humans, Politics, Uncertainty.
DOI: 10.1016/j.ijantimicag.2020.106174
PubMed: 33408020
PubMed Central: PMC7836516
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.</title>
<author><name sortKey="Goldman, Jason D" sort="Goldman, Jason D" uniqKey="Goldman J" first="Jason D" last="Goldman">Jason D. Goldman</name>
<affiliation wicri:level="2"><nlm:affiliation>Divisions of Infectious Disease and Organ Transplant, Swedish Medical Center, Seattle, WA, United States. Electronic address: jason.goldman@swedish.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Divisions of Infectious Disease and Organ Transplant, Swedish Medical Center, Seattle, WA</wicri:regionArea>
<placeName><region type="state">Washington (État)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Diaz, George" sort="Diaz, George" uniqKey="Diaz G" first="George" last="Diaz">George Diaz</name>
<affiliation wicri:level="1"><nlm:affiliation>Divisions of Infectious Disease, Providence Regional Medical Center, Everett WA, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Divisions of Infectious Disease, Providence Regional Medical Center, Everett WA</wicri:regionArea>
<wicri:noRegion>Everett WA</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Urba, Walter J" sort="Urba, Walter J" uniqKey="Urba W" first="Walter J" last="Urba">Walter J. Urba</name>
<affiliation wicri:level="2"><nlm:affiliation>Divisions of Hematology and Medical Oncology, Providence Cancer Institute Franz Clinic, Portland, OR, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Divisions of Hematology and Medical Oncology, Providence Cancer Institute Franz Clinic, Portland, OR</wicri:regionArea>
<placeName><region type="state">Oregon</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2021">2021</date>
<idno type="RBID">pubmed:33408020</idno>
<idno type="pmid">33408020</idno>
<idno type="doi">10.1016/j.ijantimicag.2020.106174</idno>
<idno type="pmc">PMC7836516</idno>
<idno type="wicri:Area/Main/Corpus">000538</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000538</idno>
<idno type="wicri:Area/Main/Curation">000538</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000538</idno>
<idno type="wicri:Area/Main/Exploration">000538</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.</title>
<author><name sortKey="Goldman, Jason D" sort="Goldman, Jason D" uniqKey="Goldman J" first="Jason D" last="Goldman">Jason D. Goldman</name>
<affiliation wicri:level="2"><nlm:affiliation>Divisions of Infectious Disease and Organ Transplant, Swedish Medical Center, Seattle, WA, United States. Electronic address: jason.goldman@swedish.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Divisions of Infectious Disease and Organ Transplant, Swedish Medical Center, Seattle, WA</wicri:regionArea>
<placeName><region type="state">Washington (État)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Diaz, George" sort="Diaz, George" uniqKey="Diaz G" first="George" last="Diaz">George Diaz</name>
<affiliation wicri:level="1"><nlm:affiliation>Divisions of Infectious Disease, Providence Regional Medical Center, Everett WA, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Divisions of Infectious Disease, Providence Regional Medical Center, Everett WA</wicri:regionArea>
<wicri:noRegion>Everett WA</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Urba, Walter J" sort="Urba, Walter J" uniqKey="Urba W" first="Walter J" last="Urba">Walter J. Urba</name>
<affiliation wicri:level="2"><nlm:affiliation>Divisions of Hematology and Medical Oncology, Providence Cancer Institute Franz Clinic, Portland, OR, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Divisions of Hematology and Medical Oncology, Providence Cancer Institute Franz Clinic, Portland, OR</wicri:regionArea>
<placeName><region type="state">Oregon</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">International journal of antimicrobial agents</title>
<idno type="eISSN">1872-7913</idno>
<imprint><date when="2021" type="published">2021</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-Bacterial Agents (therapeutic use)</term>
<term>Antimalarials (therapeutic use)</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Azithromycin (therapeutic use)</term>
<term>COVID-19 (drug therapy)</term>
<term>COVID-19 (virology)</term>
<term>Clinical Trials as Topic (MeSH)</term>
<term>Drug Combinations (MeSH)</term>
<term>Drug Repositioning (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>Politics (MeSH)</term>
<term>SARS-CoV-2 (pathogenicity)</term>
<term>Uncertainty (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Antibactériens (usage thérapeutique)</term>
<term>Antipaludiques (usage thérapeutique)</term>
<term>Antiviraux (usage thérapeutique)</term>
<term>Association médicamenteuse (MeSH)</term>
<term>Azithromycine (usage thérapeutique)</term>
<term>Essais cliniques comme sujet (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Hydroxychloroquine (usage thérapeutique)</term>
<term>Incertitude (MeSH)</term>
<term>Politique (MeSH)</term>
<term>Repositionnement des médicaments (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Bacterial Agents</term>
<term>Antimalarials</term>
<term>Antiviral Agents</term>
<term>Azithromycin</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>COVID-19</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>SARS-CoV-2</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antibactériens</term>
<term>Antipaludiques</term>
<term>Antiviraux</term>
<term>Azithromycine</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>COVID-19</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Clinical Trials as Topic</term>
<term>Drug Combinations</term>
<term>Drug Repositioning</term>
<term>Humans</term>
<term>Politics</term>
<term>Uncertainty</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Association médicamenteuse</term>
<term>Essais cliniques comme sujet</term>
<term>Humains</term>
<term>Incertitude</term>
<term>Politique</term>
<term>Repositionnement des médicaments</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33408020</PMID>
<DateCompleted><Year>2021</Year>
<Month>01</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>03</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1872-7913</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>57</Volume>
<Issue>1</Issue>
<PubDate><Year>2021</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>International journal of antimicrobial agents</Title>
<ISOAbbreviation>Int J Antimicrob Agents</ISOAbbreviation>
</Journal>
<ArticleTitle>Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.</ArticleTitle>
<Pagination><MedlinePgn>106174</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0924-8579(20)30380-0</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijantimicag.2020.106174</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Goldman</LastName>
<ForeName>Jason D</ForeName>
<Initials>JD</Initials>
<AffiliationInfo><Affiliation>Divisions of Infectious Disease and Organ Transplant, Swedish Medical Center, Seattle, WA, United States. Electronic address: jason.goldman@swedish.org.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Diaz</LastName>
<ForeName>George</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Divisions of Infectious Disease, Providence Regional Medical Center, Everett WA, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Urba</LastName>
<ForeName>Walter J</ForeName>
<Initials>WJ</Initials>
<AffiliationInfo><Affiliation>Divisions of Hematology and Medical Oncology, Providence Cancer Institute Franz Clinic, Portland, OR, United States.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>Int J Antimicrob Agents</MedlineTA>
<NlmUniqueID>9111860</NlmUniqueID>
<ISSNLinking>0924-8579</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000962">Antimalarials</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004338">Drug Combinations</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>83905-01-5</RegistryNumber>
<NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Int J Antimicrob Agents. 2021 Jan;57(1):106241</RefSource>
<PMID Version="1">33408031</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000962" MajorTopicYN="N">Antimalarials</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017963" MajorTopicYN="N">Azithromycin</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004338" MajorTopicYN="N">Drug Combinations</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058492" MajorTopicYN="N">Drug Repositioning</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011057" MajorTopicYN="N">Politics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
<QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D035501" MajorTopicYN="N">Uncertainty</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>04</Month>
<Day>11</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>08</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2021</Year>
<Month>1</Month>
<Day>7</Day>
<Hour>5</Hour>
<Minute>53</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2021</Year>
<Month>1</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2021</Year>
<Month>1</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">33408020</ArticleId>
<ArticleId IdType="pii">S0924-8579(20)30380-0</ArticleId>
<ArticleId IdType="doi">10.1016/j.ijantimicag.2020.106174</ArticleId>
<ArticleId IdType="pmc">PMC7836516</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Clin Infect Dis. 2020 Jul 28;71(15):732-739</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32150618</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Discov. 2020 Mar 18;6:16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32194981</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Oregon</li>
<li>Washington (État)</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Washington (État)"><name sortKey="Goldman, Jason D" sort="Goldman, Jason D" uniqKey="Goldman J" first="Jason D" last="Goldman">Jason D. Goldman</name>
</region>
<name sortKey="Diaz, George" sort="Diaz, George" uniqKey="Diaz G" first="George" last="Diaz">George Diaz</name>
<name sortKey="Urba, Walter J" sort="Urba, Walter J" uniqKey="Urba W" first="Walter J" last="Urba">Walter J. Urba</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000044 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000044 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidChloroV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:33408020 |texte= Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:33408020" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a CovidChloroV1
![]() | This area was generated with Dilib version V0.6.38. | ![]() |